Explore All Access
Check if your research matches the topics covered in Cancer Gene Therapy?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Cancer Gene Therapy : Impact Factor & More
eISSN: 1476-5500pISSN: 0929-1903
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Cancer Gene Therapy Key Metrics
CiteScore 
8.4
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q2Cancer Research
SNIP
0.97
Time to Accept
4
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months14%
4 to 6 months59%
7 to 9 months23%
Above 9 months4%
Did you find this useful?
Topics Covered on Cancer Gene Therapy
Immunotherapy
Tumor progression
Lung cancer
Hepatocellular carcinoma
Overall survival
Neuroendocrine tumors
Necrotic tumor
CYP3A4
Renal carcinoma
Lung
Cancer-Associated Fibroblasts
Tumor growth
Breast cancer
Extracellular vesicles
Autophagy
Chimeric antigen receptor
Cell cycle
Prostate cancer
Carcinogenesis
Glioblastoma
Cancer Gene Therapy Journal Specifications
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cancer Gene Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Gene Therapy
Serum small extracellular vesicles-derived BST2 as a biomarker for papillary thyroid microcarcinoma promotes lymph node metastasis
- 18 Nov 2024
- Cancer Gene Therapy
Ammonia death: a novel potential strategy to augment immunotherapy in cancer.
- 11 Nov 2024
- Cancer gene therapy
Overexpression of Pin1 regulated by TOP2A, which subsequently stabilizes Pyk2 to promote bortezomib resistance in multiple myeloma.
- 7 Nov 2024
- Cancer gene therapy
Novel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma.
- 5 Nov 2024
- Cancer gene therapy
Role of non-coding RNA in lineage plasticity of prostate cancer.
- 4 Nov 2024
- Cancer gene therapy
BAIAP2L2 promotes the malignancy of hepatocellular carcinoma via GABPB1-mediated reactive oxygen species imbalance.
- 4 Nov 2024
- Cancer gene therapy
Serum small extracellular vesicles-derived BST2 as a biomarker for papillary thyroid microcarcinoma promotes lymph node metastasis
- 18 Nov 2024
- Cancer Gene Therapy
Ammonia death: a novel potential strategy to augment immunotherapy in cancer.
- 11 Nov 2024
- Cancer gene therapy
Overexpression of Pin1 regulated by TOP2A, which subsequently stabilizes Pyk2 to promote bortezomib resistance in multiple myeloma.
- 7 Nov 2024
- Cancer gene therapy
Novel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma.
- 5 Nov 2024
- Cancer gene therapy
Role of non-coding RNA in lineage plasticity of prostate cancer.
- 4 Nov 2024
- Cancer gene therapy
BAIAP2L2 promotes the malignancy of hepatocellular carcinoma via GABPB1-mediated reactive oxygen species imbalance.
- 4 Nov 2024
- Cancer gene therapy
Compare Similar Journals with Cancer Gene Therapy
Select Journals to Compare with Cancer Gene Therapy
Total journals - 10
You can select up to 3 Journals at a time
Cancers
Publisher: MDPI
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Oncotarget
Publisher: Impact Journals
OncoTargets and Therapy
Publisher: DOVE MEDICAL PRESS LTD
International Journal of Molecular Sciences
Publisher: MDPI
Oncology Letters
Publisher: SPANDIDOS PUBL LTD
Cancer Letters
Publisher: ELSEVIER IRELAND LTD
Scientific Reports
Publisher: NATURE PORTFOLIO
Cell Death and Disease
Publisher: SPRINGERNATURE
0 Journals Selected to compare with
Cancer Gene Therapy
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Cancer Gene Therapy
How long has Cancer Gene Therapy been actively publishing? 
Cancer Gene Therapy has been in operation since 1994 till date.
What is the publishing frequency of Cancer Gene Therapy?
Cancer Gene Therapy published with a Monthly frequency.
How many articles did Cancer Gene Therapy publish last year?
In 2023, Cancer Gene Therapy publsihed 140 articles.
What is the eISSN & pISSN for Cancer Gene Therapy?
For Cancer Gene Therapy, eISSN is 1476-5500 and pISSN is 0929-1903.
What is Citescore for Cancer Gene Therapy?
Citescore for Cancer Gene Therapy is 8.4.
What is SNIP score for Cancer Gene Therapy?
SNIP score for Cancer Gene Therapy is 0.97.
What is the SJR for Cancer Gene Therapy?
SJR for Cancer Gene Therapy is Q2.
Who is the publisher of Cancer Gene Therapy?
SPRINGERNATURE is the publisher of Cancer Gene Therapy.
